Bradford Crutchfield - 13 May 2022 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
Chief Commercial Officer
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact for Bradford Crutchfield
Issuer symbol
TXG
Transactions as of
13 May 2022
Net transactions value
+$6,397
Form type
4
Filing time
17 May 2022, 17:25:54 UTC
Previous filing
24 Feb 2022
Next filing
25 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Purchase $6,397 +158 +0.16% $40.49 97,523 13 May 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purchase was made under the Issuer's 2019 Employee Stock Purchase Plan in a transaction exempt from Section 16(b) under Rule 16b-3(c).